Atomistry » Chlorine » PDB 9h3e-9ji6 » 9hy2
Atomistry »
  Chlorine »
    PDB 9h3e-9ji6 »
      9hy2 »

Chlorine in PDB 9hy2: Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration)

Protein crystallography data

The structure of Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration), PDB code: 9hy2 was solved by L.Raucci, M.Orlandini, C.Pozzi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 32.21 / 1.70
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 64.42, 64.42, 161.124, 90, 90, 120
R / Rfree (%) 17.7 / 21.1

Other elements in 9hy2:

The structure of Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration) also contains other interesting chemical elements:

Sodium (Na) 2 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration) (pdb code 9hy2). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration), PDB code: 9hy2:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 9hy2

Go back to Chlorine Binding Sites List in 9hy2
Chlorine binding site 1 out of 2 in the Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration)


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl306

b:43.4
occ:1.00
O A:HOH510 3.1 49.2 1.0
N A:GLY238 3.1 34.4 1.0
N A:GLN140 3.2 29.1 1.0
CA A:GLY238 3.6 33.1 1.0
CA A:THR139 3.8 34.8 1.0
O A:LEU138 3.9 36.9 1.0
CB A:GLN140 4.0 32.4 1.0
C A:THR139 4.0 33.4 1.0
CA A:GLN140 4.0 30.4 1.0
O A:HOH409 4.1 55.7 1.0
O A:GLN140 4.1 33.1 1.0
CG A:GLN140 4.2 33.7 1.0
C A:GLY237 4.2 35.2 1.0
C A:GLY238 4.4 31.7 1.0
O A:HOH585 4.5 55.7 1.0
CA A:GLY237 4.5 28.7 1.0
CG2 A:THR139 4.5 39.0 1.0
C A:GLN140 4.5 33.4 1.0
N A:GLY239 4.6 31.7 1.0
O A:HOH599 4.6 59.1 1.0
C A:LEU138 4.7 35.9 1.0
N A:THR139 4.7 32.6 1.0
CB A:THR139 4.8 36.8 1.0
CG2 A:THR143 4.9 39.9 1.0

Chlorine binding site 2 out of 2 in 9hy2

Go back to Chlorine Binding Sites List in 9hy2
Chlorine binding site 2 out of 2 in the Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration)


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Sc-4E (Scfv Derived From the Mab 4E1 Against CD93) Crystallized at pH 7.5 (Monomeric State From Gel Filtration) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl307

b:43.2
occ:1.00
OG A:SER141 2.9 40.6 1.0
O A:HOH605 2.9 43.7 1.0
O A:HOH493 3.0 51.3 1.0
CA A:PRO142 3.6 31.9 1.0
CB A:SER141 3.9 36.5 1.0
CA A:SER141 4.0 32.6 1.0
NA A:NA305 4.1 50.2 1.0
O A:HOH600 4.2 53.9 1.0
N A:THR143 4.3 33.8 1.0
CB A:PRO142 4.3 33.2 1.0
C A:PRO142 4.4 35.8 1.0
N A:PRO142 4.5 31.1 1.0
C A:SER141 4.6 33.2 1.0
O A:GLN140 4.7 33.1 1.0
CG2 A:THR143 4.9 39.9 1.0

Reference:

L.Raucci, C.D.Perrone, S.Barbera, L.J.De Boer, G.M.Tosi, J.Brunetti, L.Bracci, C.Pozzi, F.Galvagni, M.Orlandini. Structural and Antigen-Binding Surface Definition of An Anti-CD93 Monoclonal Antibody For the Treatment of Degenerative Vascular Eye Diseases. Int.J.Biol.Macromol. V. 309 43118 2025.
ISSN: ISSN 0141-8130
PubMed: 40228767
DOI: 10.1016/J.IJBIOMAC.2025.143118
Page generated: Sun Jul 13 17:02:35 2025

Last articles

Cu in 1RK5
Cu in 1RKY
Cu in 1QNI
Cu in 1R1C
Cu in 1RJP
Cu in 1RJO
Cu in 1RCY
Cu in 1R5A
Cu in 1QLE
Cu in 1PU0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy